Cytokinetics Inc (NAS:CYTK)
$ 59.23 -0.91 (-1.51%) Market Cap: 6.21 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Cytokinetics Inc Annual Shareholders Meeting Transcript

May 10, 2022 / 05:00PM GMT
Release Date Price: $37.89 (+8.35%)
John Tannahill Henderson
Cytokinetics, Incorporated - Independent Chairman

(technical difficulty) Chairman of Cytokinetics Board of Directors, and I welcome you to our 2022 Annual Meeting of Stockholders. The meeting is now called to order. John Faurescu, Vice President, Corporate and Legal and Assistant Secretary, will record in the minutes.

Before proceeding to the formal business, let me introduce Robert Blum, the company's President and Chief Executive Officer, who will provide an overview of our plans for 2022 after our formal proceedings. Before proceeding, I am pleased to introduce the members of the company's management joining us today. Ching Jaw, Senior Vice President, Chief Financial Officer; Diane Weiser, Senior Vice President, Corporate Communications and Investor Relations; and Robert Wong, Vice President, Chief Accounting Officer.

I would also like to introduce Marcus Linder from Ernst & Young LLP, the company's independent registered public accounting firm, who is available to respond to appropriate questions.

Before I hand over the meeting to John

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot